ArticleClinical & translational immunology2021

Erratum: Clinical chimeric antigen receptor T-cell therapy: a new and promising treatment modality for glioblastoma.

Michael P Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.